The #BioWatch systems currently available in many metropolitan areas operate on technology that is two decades old, and less capable than the Pentagon's detectors. How can we move to a 21st Century nationwide biological detection system? Read our plan here: atlanticcouncil.org/wp-conte…

The Applicant's argument is argumentative, raises a new issue etc. With respect, we shouldn't be here. The conduct is frivolous. We are submitting an exception to the BioWatch principle (talking about costs). - Adv. Nacerodien #LRBbacklog

Action protected under biowatch principles. The endorsement and violence towards the former public protector must attract the sanction in the public protector act. No judicial shield of disenchantment in a decision can shield him.

A win not just for MVC, but for everyone who uses the courts to defend constitutional rights. The Court has reaffirmed the Biowatch principle, protecting public interest litigants from punitive costs orders when they act in good faith to hold the state accountable. Statement: myvotecounts.org.za/judgment…

#CIA #FBI #USSecurity National Biodefense Strategy Explained gemini.google.com/share/542d… The democratization of biotechnology and gene-editing tools means that transnational organized crime syndicates, proxy groups, and lone actors present a severe and evolving threat. share.google/aimode/FgomcVCC… Biological Threats to the U.S. Security: Analysis, Risks, Strategies - Google Search google.com/search?q=Biologic… Biological threats to U.S. national security are classified into naturally emerging outbreaks, accidental laboratory releases, and deliberate bioweapons or bioterrorism. These risks—which can devastate public health, agriculture, and the economy—are actively amplified by hostile state actors, rapidly evolving biotechnology, and unregulated artificial intelligence. [1, 2, 3, 4, 5] Analysis of Threats Dual-Use Technologies & AI: The convergence of advanced biotechnology, artificial intelligence, and Large Language Models (LLMs) allows for the engineering of highly potent synthetic pathogens. These technologies can potentially lower the barrier to entry for non-state actors to develop or modify biological agents. Hostile State Actors: Adversaries like Russia and North Korea maintain chemical and biological weapons programs, while nations like China and Iran actively conduct research and development with dual-use potential. Supply Chain Vulnerabilities: The U.S. relies heavily on foreign biopharmaceutical and medical supply manufacturing (particularly in China), which creates critical dependencies that foreign powers can leverage or restrict during a biological crisis. Natural & Accidental Hazards: Zoonotic spillovers, climate-driven pathogen spread, and biosafety breaches in high-containment (BSL-3 and BSL-4) laboratories pose continuous risks of catastrophic global outbreaks. [1, 2, 3, 5, 6] Strategic Risks Global Catastrophic Biological Risks (GCBRs): Events capable of causing sudden, widespread disaster on a scale that overwhelms national and global response capabilities. The U.S. Intelligence Community consistently warns that unchecked outbreaks could lead to loss of life on a massive scale and cause sustained damage to global societal stability. Agricultural & Economic Disruption: Biological agents targeting crops or livestock threaten the U.S. food supply and result in billions of dollars in economic losses. Biosecurity Breaches: Unsecured microbial repositories, gaps in local disease surveillance networks, and loose oversight of genetic data collection remain significant vulnerabilities. [1, 2, 7, 8, 9] Strategic Frameworks & Mitigation , which restricts U.S. federal agencies from procuring biotechnology or services from designated foreign adversaries, protecting sensitive genetic data.Legislative Action: Congress and federal agencies prioritize countermeasures like theBIOSECURE Act The National Biodefense Strategy (NBS): The U.S. government implements a whole-of-government approach to assess, prevent, prepare for, and respond to biological incidents. This includes the funding of public health communication infrastructures and multilevel networks of diagnostic laboratories. Modernizing Biosurveillance: Working groups and bipartisan alliances continuously push for improved early detection mechanisms and robust international engagement to stop infectious disease outbreaks at their source before they cross borders. [4, 10, 11, 12, 13, 14] If you are interested, I can provide: More details on specific pathogens listed as Category A bioterrorism agents A breakdown of the legislative mechanisms in the BIOSECURE Act An overview of current AI regulations regarding biotechnology [3, 12, 13, 15] Let me know which area you would like to explore further. AI responses may include mistakes. [1] centerforhealthsecurity.org/… [2] councilonstrategicrisks.org/… [3] youtube.com/watch?v=RxqrAXdU… [4] aspr.hhs.gov/biodefense/Page… [5] pmc.ncbi.nlm.nih.gov/article… [6] trumpwhitehouse.archives.gov… [7] nationalacademies.org/read/2… [8] biodefensecommission.org/wp-… [9] congress.gov/event/109th-con… [10] csis.org/analysis/protecting… [11] bidenwhitehouse.archives.gov… [12] youtube.com/watch?v=IaDeO_XU… [13] youtube.com/watch?v=qByV-TNp… [14] cdc.gov/mmwr/preview/mmwrhtm… [15] youtube.com/watch?v=LmEX2kot… - AI Mode: Biological threats pose a severe and evolving challenge to U.S. national security, encompassing natural pandemics, accidental laboratory leaks, and deliberate acts of bioterrorism. To counter these complex hazards, the U.S. government relies on a multi-agency National Biodefense Strategy focused on a doctrine of "deterrence by denial" to make biological weapons obsolete through rapid detection and response capabilities. [1, 2, 3, 4, 5] 🔬 Threat Analysis: The Evolving Bio-Landscape The modern biological threat matrix is no longer limited to legacy weaponized pathogens. It is heavily shaped by geopolitical friction and exponential leaps in technology: [6, 7] State-Sponsored Capabilities: The U.S. Intelligence Community identifies persistent bioweapons capabilities and advanced research programs in nations such as Russia, North Korea, China, and Iran. The Convergence of AI and Biotech: The commercialization of Biological Design Tools (BDTs) and Large Language Models (LLMs) has drastically lowered technical barriers. Novice actors can now source actionable information to plan biological attacks, while advanced tools assist in engineering novel, vaccine-evading pathogens. Data and Supply Chain Vulnerabilities: Adversarial collection of global health and genetic data (multiomics) poses long-term profiling risks. Concurrently, foreign dominance over critical pharmaceutical ingredients and medical supply lines creates a severe strategic bottleneck. [8, 9, 10, 11] ⚠️ Primary Strategic Risks A comprehensive risk assessment by the Center for Health Security divides biological dangers into three distinct categories: [3, 12, 13, 14] ┌───────────────────────────────┐ │ U.S. BIOLOGICAL RISKS │ └───────────────┬───────────────┘ ┌────────────────────────────┼────────────────────────────┐ ▼ ▼ ▼ ┌───────────────────┐ ┌───────────────────┐ ┌───────────────────┐ │ DELIBERATE │ │ ACCIDENTAL │ │ NATURAL │ ├───────────────────┤ ├───────────────────┤ ├───────────────────┤ │ • Bioterrorism │ │ • Lab leaks/escapes│ │ • Novel pandemics │ │ • State programs │ │ • Cyber theft of │ │ • Antimicrobial │ │ • Agro-terrorism │ │ pathogen data │ │ resistance │ └───────────────────┘ └───────────────────┘ └───────────────────┘ Global Catastrophic Biological Risks (GCBRs): These are sudden, widespread events capable of causing over 100 million deaths, collapsing national economies, and destabilizing global security. Laboratory and Research Biosafety: The rapid multiplication of high-containment Biosafety Level 4 (BSL-4) labs globally increases the statistical probability of accidental pathogen escapes or insider theft. Agricultural and Environmental Threats: Weaponized pathogens targeting livestock or vital food crops (agro-terrorism) can paralyze the American agribusiness sector and cripple food security. [12, 15, 16, 17, 18] 🛡️ U.S. Counterstrategies & Mitigation Plans The United States addresses these risks through an integrated framework of domestic policies and international programs: [19] 1. Advanced Biosurveillance and Data Isolation [20] Early Warning Systems: Federal systems utilize automated syndromic surveillance, such as ESSENCE, to monitor global real-time health data for early signs of anomalous outbreaks. The Biosecure Act: Legislative efforts strictly prohibit U.S. federal agencies from procuring equipment or collaborating with foreign biotechnology firms tied to foreign adversaries. This shields sensitive American genetic datasets from exploitation. [11, 20, 21, 22] 2. Threat Characterization and Forensics NBACC Research: The National Biodefense Analysis and Countermeasures Center (NBACC) runs maximum-security BSL-4 facilities. It executes forensic testing to definitively attribute the origins of biocrimes or biological accidents. The Federal Select Agent Program: Managed jointly by the FBI's Bioterrorism Risk Assessment Group (BRAG) and health officials, this program strictly vets individuals seeking access to high-consequence biological toxins. [23, 24, 25, 26, 27] 3. AI Guardrails and Agile Response Synthesized DNA Screening: Modern protocols require providers of genetic synthesis to rigorously screen customers and cloud-laboratory requests to prevent the unauthorized creation of regulated agents. Inter-Agency All-Hazards Response: Domestic defense structures bind the Department of Homeland Security (DHS), Health and Human Services (HHS), and the CDC to execute regional medical countermeasures, distribution of the Strategic National Stockpile, and mass vaccination strategies. [4, 28, 29, 30, 31] To explore specific areas of biodefense further, please let me know if you would like to look closer into AI biosecurity guardrails, examine the Biosecure Act's supply chain impacts, or analyze the inter-agency logistics of an epidemic response. [1] councilonstrategicrisks.org [2] csis.org [3] aspr.hhs.gov [4] youtube.com [5] en.wikipedia.org [6] pmc.ncbi.nlm.nih.gov [7] marketsandmarketsblog.com [8] councilonstrategicrisks.org [9] tandfonline.com [10] csis.org [11] councilonstrategicrisks.org [12] centerforhealthsecurity.org [13] ijtsrd.com [14] pmc.ncbi.nlm.nih.gov [15] biodefensecommission.org [16] youtube.com [17] pmc.ncbi.nlm.nih.gov [18] theanimalecho.woah.org [19] linkedin.com [20] bidenwhitehouse.archives.gov [21] ncbi.nlm.nih.gov [22] youtube.com [23] media.defense.gov [24] dhs.gov [25] fbi.gov [26] safetyact.gov [27] dhs.gov [28] cnas.org [29] cdc.gov [30] armscontrol.org [31] vox.com - Gemini: Biological Threats: U.S. Security Analysis gemini.google.com/share/2185… The landscape of biological threats to U.S. national security has fundamentally shifted. For decades, biodefense was viewed through the narrow lens of countering specific terrorist plots or securing legacy stockpiles left over from the Cold War. Today, the convergence of rapid advancements in biotechnology, the democratization of artificial intelligence, and the proliferation of high-containment laboratories has created a highly complex, multi-vector threat environment. Addressing these threats requires moving beyond traditional public health paradigms and integrating biodefense directly into grand strategy, intelligence operations, and national security architecture. The Threat Landscape: A Multi-Vector Environment Biological threats are generally categorized into three origins: deliberate, accidental, and natural. From a national security perspective, the lines between these vectors are increasingly blurred, as the strategic impact of a biological event is catastrophic regardless of its source. State-Sponsored Programs: The intelligence community assesses that nations like Russia and North Korea maintain active biological weapons programs in violation of the Biological Weapons Convention (BWC). China's compliance remains ambiguous due to insufficient verification data. In modern conflict, state actors may view biological agents not just as weapons of mass destruction, but as tools for strategic disruption—inflicting economic damage, eroding military readiness, or destabilizing civilian populations below the threshold of nuclear retaliation. The State-Crime Nexus and Non-State Actors: The traditional barrier to entry for biological weapons was the massive infrastructure required for research, testing, and weaponization. However, transnational organized crime networks and proxy groups present a unique risk. These networks can facilitate the illicit procurement of dual-use equipment, precursor materials, or even genetic sequences, bridging the gap between state-level intent and deniable, non-state execution. Accidental and Natural Risks: The global proliferation of high-containment laboratories researching high-consequence pathogens increases the statistical probability of an accidental leak. Simultaneously, the accelerating frequency of zoonotic spillover events poses a persistent threat to economic stability, military readiness, and public health infrastructure. The Technology Multiplier: AI and Synthetic Biology The intersection of artificial intelligence and synthetic biology is perhaps the most significant disruptive force in modern biosecurity. Accelerating the Threat Historically, developing a functional biological weapon required specialized, tacit knowledge—the kind acquired only through years of hands-on laboratory experience. Today, large language models and specialized foundation models are beginning to bridge this knowledge gap. AI systems can assist malicious actors in troubleshooting failed experiments, optimizing pathogen transmissibility, or identifying vulnerabilities in target populations. Combined with accessible DNA synthesis and CRISPR gene-editing technologies, the "design-build-test-learn" cycle for creating novel pathogens is becoming faster, cheaper, and harder to track. AI and OSINT as Defensive Assets Conversely, AI and open-source intelligence (OSINT) are critical to modern biosurveillance. Traditional intelligence gathering is often too slow to detect an emerging biological threat. By aggregating and analyzing vast streams of open-source data—social media trends, localized supply chain disruptions, health care data, and even global flight patterns—AI tools can identify epidemiological anomalies weeks before official reporting channels flag them. Strategic Responses and Intelligence Evolution The U.S. strategy is increasingly shifting toward deterrence by denial—making the homeland so resilient, and detection so rapid, that an adversary calculates a biological attack will fail to achieve its strategic objectives. Executing this strategy requires significant structural evolution within the intelligence and security apparatus. 1. Overcoming Intelligence Fragmentation Historically, biosurveillance has suffered from chronic fragmentation, stove-piped across the CDC, the USDA, legacy programs like BioWatch, and various intelligence agencies. Effective biodefense requires a centralized, cohesive intelligence structure. Evolving counterintelligence services—such as the FBI and the CIA—must prioritize biological threat intelligence on par with cyber threats or nuclear proliferation. Re-establishing and empowering a dedicated biological threat directorate within the Office of the Director of National Intelligence (ODNI) is critical for synthesizing classified intelligence with global health data and OSINT. 2. Modernizing Biosurveillance Networks Early warning is the linchpin of biodefense. The U.S. must expand its reliance on agnostic detection systems that do not require prior knowledge of a specific pathogen. This includes scaling wastewater surveillance at international airports, military installations, and embassies. Advanced molecular detection and genomic sequencing must be integrated into a real-time, global surveillance network to identify engineered or novel pathogens at the point of origin. 3. Securing the Bio-Economy and Supply Chains The U.S. remains heavily reliant on foreign supply chains for active pharmaceutical ingredients (APIs), personal protective equipment, and essential laboratory supplies. A core pillar of biosecurity strategy is reshoring or near-shoring the manufacturing of critical medical countermeasures and maintaining warm-base production capacity to ensure the U.S. can respond rapidly to an outbreak without supply chain blackmail. -

Dani Biowatch made by _spodumene_

from DHS biowatch program post 9/11

Really poorly-reasoned judgment. It mixes up so many administrative law principles while it claims not to engage administrative law. Bizarrely, it says the Biowatch principle doesn’t apply yet in the first line it says the case is about constitutional rights. Appealable.

The court noted concerns about his transfer before the hearing but said there wasn’t enough basis to rule on it. Application dismissed and applying the Biowatch principle, the court made no costs order against any party. @MongeziKoko

See para 104: Cholota arose in criminal proceedings (but not clear why Biowatch didn't apply to Schultz)

🚨 DEBRIEFING: The receipts are in the DHS FY2026 budget. This isn’t “politics.” This is capability funding the kind you approve when an operation is already moving and you need the machine built fast. What jumps off the page: ✅ Largest DHS supplemental package ever: $191.02B (P.L. 119-21, signed July 4, 2025) ✅ CBP: $64.73B including $46.55B for the border wall/infrastructure system ✅ ICE: $74.85B including $45B for detention capacity ✅ USCG: $24.59B procurement sustainment (maritime choke points, interdiction, persistence) Now the quiet part that matters: DHS proposes breaking up CWMD and embedding those functions into the operators CBP / USCG / CISA / OSEM. That includes radiation portal monitor support, BioWatch, “Securing the Cities,” training/exercise/readiness, and bio-surveillance integration. 👉And here’s the tell: CRS notes the funding has limited specificity and that no public plan for how the enacted authority will be used was available (as of Sept 1, 2025). Global Purge lens: Border detention maritime buildout CBRN/bio/radiological detection embedded into core ops… with minimal public detail. That’s what it looks like when you’re funding sustained enforcement, interdiction, and infrastructure control not a news cycle. ⏳ Timeline never lies. Hat tip on the Coast Guard node: @Homeranger17 🇺🇸⚓️.. @AstuteActual @ccblanchard99 @THEDuaneCates

I made my first weather forecasts around chemtrails in March 2002 when I was 20. The CIA showed up soon after. It's been a 23 yr fight. It didn't matter how many long range forecasts I made 10 days in advance, it didn't matter I earned a 4.0 through a Master's program at MSState in Meteorology, it didn't matter that I had records from the Biowatch program that tracked aerosol density going back to 2005 that could link it, it didn't matter I found designs burned through the clouds, it didn't matter that solar panel companies reported substantial decreases on spray days, it didn't matter precipitation was cut up at 300mph on radar...it was all a hoax and I was target number 1 until Dane came along. Thank you for taking some of the heat Dane!

Inside Medicine: What is BioWatch and why is it offline? by @jeremyfaust bit.ly/4qsFIzM

Luckily we’ve nvr had to activate JTF-CS. I hope we won’t see that day. DHS’ BIOWATCH pgm (currently under CWMD office) is a great sentinel but always struggles for funding. They have to be looked after every year via discretionary funding. They are being moved under CISA per FY26 budget guidelines. This is publicly available info.

WHO IS SUSAN MONAREZ? Susan Monarez, PhD, was CDC Director for just a few weeks, having been sworn in on July 31 after Senate confirmation on July 29. With her background in microbiology, immunology, and over 20 years in government roles focused on health innovation, biosecurity, and pandemic preparedness (including stints at ARPA-H, the White House Office of Science and Technology Policy, the National Security Council, and the Department of Homeland Security). Monarez stepped into a challenging position amid budget cuts, staff reductions, and political shifts under HHS Secretary Robert F. Kennedy Jr., and, most recently, a law suit filed by Doctors Paul Thomas and Kenneth Stoller in which she is named, (Thomas v. Monarez) which is customary in suits filed against government agencies. She's the first non-physician to lead the CDC in about 70 years, which prompted some questions about her qualifications. From her prior roles, she's advocated for: -Ethical AI and data use in health: She led efforts on AI/machine learning for better health outcomes, including privacy protections for personal health data and wearable tech integration. -Addressing epidemics and disparities: Work on ending the opioid crisis, reducing maternal morbidity/mortality (especially disparities), improving organ donation, and combating antimicrobial resistance. -Biosecurity and innovation: At DHS and ARPA-H, she shaped some strategies for biomedical innovation, including BARDA's BioShield funding for pharma and Pentagon labs, and programs for implantable devices, AI diagnostics, and genetic databases. Critics, like investigative reports from Unlimited Hangout, allege her policies reflect a "militarization of healthcare" with ties to biosurveillance (e.g., tools like malintent detectors and BioWatch) and rebranded eugenics networks, potentially expanding data-sharing under the pretext of national security). Other notes: Monarez faced criticism online mRNA vaccine advocacy (from her biosecurity background) and changes to CDC dashboards (e.g., wastewater data re-binning, seen by some as downplaying transmission). During Monarez’s short stint, the CDC encouraged people to take Bill Gates’ new, experimental Chikungunya vaccine which was pulled shortly after approval and only days before Monarez left her post. According to the Washington Post, Monarez clashed with HHS Secretary Robert F. Kennedy Jr. over COVID vaccine policy changes and tried to get Sen. Bill Cassidy (R-La.) to intervene after Kennedy urged her to resign. The same day she resigned, HHS announced it will limit who is eligible for COVID vaccines.

I can no longer call my dystopian utilitarian alien mecha force ‘BioWatch’ because that is a real life government institution. >.> so now I need a new name

Developers are using LitServe to deploy GenAI models in minutes, not days. 🚀 Fast setup, zero mlops fuss ⚙️ Flexible config 📦 Deploy to cloud, edge, or anywhere in between 📈 Proven performance at scale Trusted by founders engineers building: 🧠 Physical AI (@GetSoloTech) 💬 Scalable GenAI inference (Synthera AI) 📊 APIs for research and prod (Mind the Math) 🦌 Wildlife monitoring (Biowatch, Cameratrapai) Try it out → go.lightning.ai/3UwXFhE Or DM us for help getting started.

Austin's BioWatch program -- which is intended to detect bioterrorism -- may be in jeopardy. During a TravCo Commissioners meeting APH said federal funding cuts are impacting this program too: kxan.com/news/local/austin/a…